Ovarian Adrenal Rest Tumor in a Congenital Adrenal Hyperplasia Patient with Adrenocorticotropin Hypersecretion following Adrenalectomy
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Ovarian adrenal rest tumors (OARTs) are rare in contrast to testicular adrenal rest tumors. We report a case of OART in a patient with congenital adrenal hyperplasia who developed Nelson's syndrome after bilateral adrenalectomy. METHODS: We describe the clinical, imaging, and laboratory findings of the patient and review the relevant literature regarding OART and the possible interaction between ACTH and brown adipose tissue. RESULTS: An 18-year-old female with congenital adrenal hyperplasia, who had undergone bilateral adrenalectomy at the age of 10 years, presented with severe hyperpigmentation and hirsutism. Rectal ultrasonography showed a mass in the right ovary. (18)F-fluorodeoxyglucose PET/CT revealed intense uptake both in this mass and in brown adipose tissue located in typical supradiaphragmatic sites. Laparoscopic removal of the ovarian mass confirmed the diagnosis of OART. A systematic review revealed 9 documented cases of OART. As in our case, all presented with elevated ACTH levels. CONCLUSIONS: Common to all documented cases of OART are sustained high ACTH levels that activate the adrenal anlagen tissue in the ovaries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adrenalectomy may not totally remove hyperandrogenemia owing to the potential development of adrenal rest tumors in the testes (330), ovaries (332), or retroperitoneum (333).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [332]
Citations
Cites
1 retracted
Baş, F., Saka, N., Darendelıler, F., Tuzlalı, S., İlhan, R., Bundak, R., & Günöz, H. (2000) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2000.13.6.663 · Cited by 29
RetractedIdentification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Female development in mammals is regulated by Wnt-4 signalling
Vainio, S., Heikkilä, M., Kispert, A., Chin, N., & McMahon, A. P. (1999) · Nature · doi:10.1038/17068 · Cited by 1,271
Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad
Jeays-Ward, K., Hoyle, C., Brennan, J., Dandonneau, M., Alldus, G., Capel, B., & Swain, A. (2003) · Development · doi:10.1242/dev.00591 · Cited by 346 · cited 1×
“These findings suggest that the difference in adrenal rest tumor incidence between males and females may be due to differences in the ontogenesis of the gonads, and not to differences in the migration of aberrant adrenal tissue.Wnt4 is one of the main transcription factors in ovarian ontogenesis. This factor represses…”
BackgroundStikkelbroeck, N. M. M. L., Otten, B. J., Pasic, A., Jager, G. J., Sweep, C. G. J. F., Noordam, K., & Hermus, A. R. M. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8090 · Cited by 305 · cited 1×
“• In contrast to the high incidence of testicular adrenal rest tumors found in males with congenital adrenal hyperplasia (CAH), ovarian adrenal rest tumors (OART) in females with CAH are very rare. Novel Insights• In cases of adrenalectomy in CAH female patients, ACTH hypersecretion and OART should be considered.• Int…”
BackgroundIdentical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF‐1
Hatano, O., Takakusu, A., Nomura, M., & Morohashi, K. (1996) · Genes to Cells · doi:10.1046/j.1365-2443.1996.00254.x · Cited by 299 · cited 1×
“The first question that arises is whether a similar migration of adrenal-like cells occurs in the ovaries. In the rat the rostral half of the adrenogenital primordium begins to separate into an adrenal cortex and gonads at 12.5 dpc. At 13.5 dpc, these two primordia have separated completely [”
BackgroundInfluentialAssié, G., Bahurel, H., Coste, J., Silvera, S., Kujas, M., Dugué, M.-A., Karray, F., Dousset, B., Bertherat, J., Legmann, P., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1328 · Cited by 230 · cited 1×
“in our case only high-dose dexamethasone treatment succeeded in suppressing ACTH secretion. Nelson’s syndrome refers to patients with Cushing’s disease in whom, following adrenalectomy, the pituitary gland responds to loss of glucocorticoid feedback inhibition by secreting excess ACTH. The gland expands, leading to hy…”
BackgroundKing, P., Paul, A., & Laufer, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909471106 · Cited by 227 · cited 1×
“proposed that TART develops from adrenal-like cells that migrate into the testis or originate from local steroidogenic stem cells. These cells express the ACTH receptor MC2R, which may regulate Shh expression that is implicated in adrenal development and differentiation [”
BackgroundBiason-Lauber, A., De Filippo, G., Konrad, D., Scarano, G., Nazzaro, A., & Schoenle, E. J. (2007) · Human Reproduction · doi:10.1093/humrep/del360 · Cited by 215 · cited 1×
“Functional studies show that the mutated Wnt4 does not suppress the expression of the androgen-synthetic enzymes CYP17A1 and HSD3B2 in human ovarian cells. The ‘escape’ from Wnt4 suppression in females with mutations in Wnt4 results in the expression of steroidogenic enzymes and in increased testosterone synthesis [”
Background
Research works printed but not linked: 4
- 10.1210%2fjc.86.12.5721 · DOI · Paper page
- 10.1111%2fj.1365-2605.2008.00924.x · DOI · Paper page
- 10.1210%2fer.21.3.245 · DOI
- 10.1210%2fjc.85.3.1211 · doi:10.1210/jc.85.3.1211
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“Adrenalectomy may not totally remove hyperandrogenemia owing to the potential development of adrenal rest tumors in the testes (330), ovaries (332), or retroperitoneum (333).”
BackgroundSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors
Mete, O., Erickson, L. A., Juhlin, C. C., de Krijger, R. R., Sasano, H., Volante, M., & Papotti, M. G. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09710-8 · Cited by 343
Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.002 · Cited by 177
Approach to the patient: the adult with congenital adrenal hyperplasia
Auchus, R. J., & Arlt, W. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1440 · Cited by 121
“Even women with classic 21OHD can develop adrenal rest tumors in the pelvic area after bilateral adrenalectomy, with recurrent androgen excess (17, 18).”
BackgroundManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Turcu, A. F., Mallappa, A., Elman, M. S., Avila, N. A., Marko, J., Rao, H., Tsodikov, A., Auchus, R. J., & Merke, D. P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3989 · Cited by 107
Clinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106
“Ovarian tumors In contrast to TARTs, ovarian adrenal rest tumors (OARTs) are very rare [141].”
BackgroundInfluentialTreatment and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Walker, B. R., Arlt, W., & Ross, R. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.239 · Cited by 102
MANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia
Claahsen-van der Grinten, H. L., Stikkelbroeck, N., Falhammar, H., & Reisch, N. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1093 · Cited by 72
Management considerations for the adult with congenital adrenal hyperplasia
Auchus, R. J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.039 · Cited by 65
Bilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
MacKay, D., Nordenström, A., & Falhammar, H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00217 · Cited by 59
“Two girls, aged 10 and 16 years at adrenalectomy, developed pituitary microadenoma (26, 37).”
BackgroundBachelot, A., Grouthier, V., Courtillot, C., Dulon, J., & Touraine, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0888 · Cited by 57
Congenital adrenal hyperplasia – pharmacologic interventions from the prenatal phase to adulthood
Claahsen-van der Grinten, H. L., Stikkelbroeck, N. M. M. L., Otten, B. J., & Hermus, A. R. M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.004 · Cited by 53
Non-classic congenital adrenal hyperplasia
Witchel, S. F. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.010 · Cited by 52
Crocker, M. K., Barak, S., Millo, C. M., Beall, S. A., Niyyati, M., Chang, R., Avila, N. A., Van Ryzin, C., Segars, J., Quezado, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2298 · Cited by 48
Non-Classical Congenital Adrenal Hyperplasia in Childhood
Kurtoğlu, S., & Hatipoğlu, N. (2017) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.3378 · Cited by 49
“Development of rest tissue and tumor in ovaries is less frequent (61).”
BackgroundNordenström, A. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834810a4 · Cited by 42
Ladjouze, A., Donaldson, M., Plotton, I., Djenane, N., Mohammedi, K., Tardy-Guidollet, V., Mallet, D., Boulesnane, K., Bouzerar, Z., Morel, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867073 · Cited by 42
Infertility and Reproductive Function in Patients with Congenital Adrenal Hyperplasia
Lekarev, O., Lin-Su, K., & Vogiatzi, M. G. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.07.009 · Cited by 38
Novel treatment strategies in congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2016) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000256 · Cited by 30
“Patients and parents should never be counseled that adrenalectomy will permanently cure the hyperandrogenemia, because of the development of adrenal rest tumors in the testes [29] in men or in the ovaries [30] and retroperitoneum [31] in women.”
BackgroundRussian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Long‐term health consequences of congenital adrenal hyperplasia
Pofi, R., Ji, X., Krone, N. P., & Tomlinson, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14967 · Cited by 30
“When routine ultrasound imaging techniques fail to detect these lesions, ultrasound or MRI, 100 18 F ‐ FDG PET/ CT, 95,96 131 I ‐ noriodocholesterol imaging, selective and pelvic venous sampling 101 can help in identifying occult OART or localise virilising ovarian tumours.”
Chen, H.-D., Huang, L.-E., Zhong, Z.-H., Su, Z., Jiang, H., Zeng, J., & Liu, J.-C. (2017) · Endocrine Pathology · doi:10.1007/s12022-016-9461-4 · Cited by 24
Substitution therapy in adult patients with congenital adrenal hyperplasia
Reisch, N. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.11.002 · Cited by 24
Bilateral Ovary Adrenal Rest Tumor in a Congenital Adrenal Hyperplasia Following Adrenalectomy
Zaarour, M. G., Atallah, D. M., Trak-Smayra, V. E., & Halaby, G. (2014) · Endocrine Practice · doi:10.4158/ep13092.cr · Cited by 24
Management aspects of congenital adrenal hyperplasia during adolescence and transition to adult care
Balagamage, C., Arshad, A., Elhassan, Y., Said, W. B., Krone, R. E., Gleeson, H. K., & Idkowiak, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14992 · Cited by 19
“120,121,123,124,127,128 The difficult access of the intra ‐ abdominally located ovaries to ultrasound imaging may explain the low reported prevalence of OARTs.”
Burman, P., Falhammar, H., Waldenström, E., Sundin, A., & Bitzèn, U. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa870 · Cited by 19
Thomas, T. T., Ruscher, K. A., Mandavilli, S. R., Balarezo, F., & Finck, C. M. (2013) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2013.04.006 · Cited by 18
“Tiosano, 2010 [6] 18 years, progressive virilizing symptoms and hyperpigmentation after bilateral adrenalectomy CAH 21-hydroxylase deficiency Right ovarian adrenal rest tumor E26 T.”
BackgroundInfluentialThe role of imaging in congenital adrenal hyperplasia
Teixeira, S. R., Elias, P. C. L., Andrade, M. T. S., Melo, A., & Elías, J. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003371 · Cited by 20
Emerging medical therapies for congenital adrenal hyperplasia
Speiser, P. (2019) · F1000Research · doi:10.12688/f1000research.17778.1 · Cited by 17
Sisto, J., Liu, F. W., Geffner, M. E., & Berman, M. L. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1441399 · Cited by 17
“young boys where ectopic remnants of adrenal cortex were incidentally found along the spermatic cord during these procedures [7].”
BackgroundInfluentialFang, B., Cho, F. K. Y., & Lam, W. W. M. (2013) · Journal of Radiology Case Reports · doi:10.3941/jrcr.v7i12.1933 · Cited by 12
Bouzidi, L., Triki, M., Charfi, S., Ameur, H. B., Dhaou, M. B., Bouaziz, T., & Boudawara, T. S. (2021) · Pediatric and Developmental Pathology · doi:10.1177/1093526620980614 · Cited by 13
“and become hyperplastic as a result of stimulation by ACTH and angiotensin II.(9) Like TART, they are not considered truly self-standing tumors.”
BackgroundTesticular tumors of adrenogenital syndrome: From physiopathology to therapy
Naouar, S., Braiek, S., & Kamel, R. E. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.05.006 · Cited by 10
der Grinten, H. L. C., Stikkelbroeck, M., Bulten, J., & den Heyer, M. (2013) · Hormone Research in Paediatrics · doi:10.1159/000354659 · Cited by 8
Health problems of adolescent and adult patients with 21-hydroxylase deficiency
Tajima, T. (2018) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.27.203 · Cited by 8
“OARTs were usually found when 21-OHD disease management was very poor and an adrenalectomy was performed (43, 44).”
BackgroundOvarian Steroid Cell Tumor Masquerading as Steroid-Unresponsive Congenital Adrenal Hyperplasia
Driano, J. E., Creo, A. L., Kumar, S., Chattha, A. J., & Lteif, A. N. (2021) · AACE Clinical Case Reports · doi:10.1016/j.aace.2021.02.001 · Cited by 6
Woman with virilizing congenital adrenal hyperplasia and leydig cell tumor of the ovary
Salazar, R. F.-G., Muñoz-Darias, C., Haro‐Mora, J. J., Almaraz, M. C., Audí, L., Martínez-Tudela, J., Yahyaoui, R., & Esteva, I. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.907260 · Cited by 5
“In this case, the finding of an ovarian mass suggests that, in addition to hyperandrogenism, secondary to CAH, one must consider in order of frequency the presence of ovarian adrenal rest tumor [1,2,3,4] or less likely, a primitive tumor as androgenproducing causal agent.”
BackgroundDiagnostic imaging in congenital adrenal hyperplasia – how does it help?
Gul, B., Claudette, P., Sarah, T., Anup, S., & Beharry, N. (2020) · Annals of Clinical Endocrinology and Metabolism · doi:10.29328/journal.acem.1001013 · Cited by 4
Freeman, R. G. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_7 · Cited by 3
Yıldız, M., Bayram, A., Baş, F., Karaman, V., Toksoy, G., Poyrazoğlu, Ş., Soysal, F. G., Önder, S. Y., Uyguner, Z. O., & Darendelıler, F. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-0913 · Cited by 4
Stuckey, B. G. A., Dedic, D., Zhang, R., Rabbah, A., Turcu, A. F., & Auchus, R. J. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae077 · Cited by 3
“The development of adrenal rest tumors in the ovaries, uterine ligaments, and surrounding retroperitoneum following adrenalectomy with return of hyperandrogenemia has also been reported [17, 18].”
BackgroundFedorova, O., & Falhammar, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1693063 · Cited by 2
Akbulut, S., Ceylan, Ş. D., Tunçalı, T., & Söğütçü, N. (2020) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00408-w · Cited by 2
Koren, R., Koren, S., Khashper, A., Benbassat, C. A., Pekar‐Zlotin, M., & Vaknin, Z. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000415 · Cited by 3
“We found only 17 case reports of OARTS in English language literature (13-27), documented in patients with CAH and various enzymatic deficiencies and patients with Nelson syndrome after bilateral adrenalectomy due to Cushing’s disease (Table 1).”
BackgroundThe Role of the Adrenal Glands in the Hyperandrogenism Associated with Polycystic Ovarian Syndrome
Freeman, R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_5 · Cited by 2
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-14881-1_59 · Cited by 2
Oddział Pediatrii, S. W. R. Ś., Borawska-Dziadek, E., Ziora-Jakutowicz, K. N., & Warszawa, I. P. I. N. (2015) · Pediatric Endocrinology · doi:10.18544/ep-01.14.02.1558 · Cited by 1
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Tseng, T., Koppin, C. M., & Geffner, M. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-17002-2_59-1 · Cited by 1
Nermoen, I. (2013) · NVA (Nasjonalt vitenarkiv)
Teixeira, S. R. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2017.tde-21102014-224356
Congenital adrenal hyperplasia with an ovarian adrenal rest tumor: a case report
Buyruk, B. A., Yorulmaz, G., Değer, A. N., & Kebapçı, M. N. (2019) · The European Research Journal · doi:10.18621/eurj.435638
“[9] in 2010, only 10 OART cases were reported.”
BackgroundManagement of Congenital Adrenal Hyperplasia in the Adult: Fertility Issues
Ross, R. J. M. (2015) · The Endocrine Society eBooks · doi:10.1210/mtp4.9781936704941.ch2
Зелінська, Н. Б. (2019) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy
Ovarian adrenal rest tumor in a patient with salt-wasting form of congenital adrenal hyperplasia
Молашенко, Н. В., Мажлумовна, Б. Д., Derkatch, D. А., Vladimirova, V. P., Soldatova, T. V., Vorontsov, A. V., Селиванова, Л. С., Troshina, E. A., Andreeva, E. N., & Ponomareva, T. A. (2020) · Endocrine Surgery · doi:10.14341/serg12340
“Предполагается, что ОART чаще возникает у пациенток с декомпенсированной ВДКН [13].”
Lack, E. E., & Paal, E. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-54941-7.00016-5
(2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283473d73
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Tseng, T., Koppin, C. M., & Geffner, M. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-17798-4_59
Management of Adult Patients With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Grouthier, V., Dulon, J., Bachelot, A., & Touraine, P. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66140-8
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-319-17002-2_59-2
Management of adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Grouthier, V., Dulon, J., Bachelot, A., & Touraine, P. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00132-1
Lack, E. E., & Paal, E. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4327-8.00016-4 · Cited by 1
Szklarz, M., Wołos-Kłosowicz, K., Szulc, J., Górny, J. M., & Matuszewski, W. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00364-8
“Adrenal rest tumours can appear in the ovaries and pelvis in women [112].”
Metadata
- Authors
- Tiosano, D., Vlodavsky, E., Filmar, S., Weiner, Z., Goldsher, D., & Bar-Shalom, R.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- ORCID
- Tiosano, Dov
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 74
- Issue
- 3
- Pages
- 223-228
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2126519381
- Cited by
- 65
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 4 · 2020: 6 · 2019: 3 · 2018: 5 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 5 · 2013: 8 · 2012: 2
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- congenital adrenal hyperplasia, Nelson's syndrome, adrenalectomy, ACTH hypersecretion, brown adipose tissue, ovarian mass, hyperpigmentation, hirsutism, 18F-FDG PET/CT
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adrenal Rest Tumor, Adrenalectomy, Adrenocorticotropic Hormone, Female, Humans, Nelson Syndrome, Ovarian Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.